mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation

Kristen N. Pollizzi, Chirag H. Patel, Im Hong Sun, Min Hee Oh, Adam T. Waickman, Jiayu Wen, Greg M. Delgoffe, Jonathan Powell

Research output: Contribution to journalArticle

Abstract

Activation of mTOR-dependent pathways regulates the specification and differentiation of CD4+ T effector cell subsets. Herein, we show that mTOR complex 1 (mTORC1) and mTORC2 have distinct roles in the generation of CD8+ T cell effector and memory populations. Evaluation of mice with a T cell-specific deletion of the gene encoding the negative regulator of mTORC1, tuberous sclerosis complex 2 (TSC2), resulted in the generation of highly glycolytic and potent effector CD8+ T cells; however, due to constitutive mTORC1 activation, these cells retained a terminally differentiated effector phenotype and were incapable of transitioning into a memory state. In contrast, CD8+ T cells deficient in mTORC1 activity due to loss of RAS homolog enriched in brain (RHEB) failed to differentiate into effector cells but retained memory characteristics, such as surface marker expression, a lower metabolic rate, and increased longevity. However, these RHEB-deficient memory-like T cells failed to generate recall responses as the result of metabolic defects. While mTORC1 influenced CD8+ T cell effector responses, mTORC2 activity regulated CD8+ T cell memory. mTORC2 inhibition resulted in metabolic reprogramming, which enhanced the generation of CD8+ memory cells. Overall, these results define specific roles for mTORC1 and mTORC2 that link metabolism and CD8+ T cell effector and memory generation and suggest that these functions have the potential to be targeted for enhancing vaccine efficacy and antitumor immunity.

Original languageEnglish (US)
Pages (from-to)2090-2108
Number of pages19
JournalJournal of Clinical Investigation
Volume125
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Cell Differentiation
T-Lymphocytes
Tuberous Sclerosis
TOR complex 2
Gene Deletion
Brain
T-Lymphocyte Subsets
Immunity
Vaccines
Phenotype
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pollizzi, K. N., Patel, C. H., Sun, I. H., Oh, M. H., Waickman, A. T., Wen, J., ... Powell, J. (2015). mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation. Journal of Clinical Investigation, 125(5), 2090-2108. https://doi.org/10.1172/JCI77746

mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation. / Pollizzi, Kristen N.; Patel, Chirag H.; Sun, Im Hong; Oh, Min Hee; Waickman, Adam T.; Wen, Jiayu; Delgoffe, Greg M.; Powell, Jonathan.

In: Journal of Clinical Investigation, Vol. 125, No. 5, 01.05.2015, p. 2090-2108.

Research output: Contribution to journalArticle

Pollizzi, KN, Patel, CH, Sun, IH, Oh, MH, Waickman, AT, Wen, J, Delgoffe, GM & Powell, J 2015, 'mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation', Journal of Clinical Investigation, vol. 125, no. 5, pp. 2090-2108. https://doi.org/10.1172/JCI77746
Pollizzi KN, Patel CH, Sun IH, Oh MH, Waickman AT, Wen J et al. mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation. Journal of Clinical Investigation. 2015 May 1;125(5):2090-2108. https://doi.org/10.1172/JCI77746
Pollizzi, Kristen N. ; Patel, Chirag H. ; Sun, Im Hong ; Oh, Min Hee ; Waickman, Adam T. ; Wen, Jiayu ; Delgoffe, Greg M. ; Powell, Jonathan. / mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation. In: Journal of Clinical Investigation. 2015 ; Vol. 125, No. 5. pp. 2090-2108.
@article{1f7fce62762f441a905d5c827b6eef3e,
title = "mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation",
abstract = "Activation of mTOR-dependent pathways regulates the specification and differentiation of CD4+ T effector cell subsets. Herein, we show that mTOR complex 1 (mTORC1) and mTORC2 have distinct roles in the generation of CD8+ T cell effector and memory populations. Evaluation of mice with a T cell-specific deletion of the gene encoding the negative regulator of mTORC1, tuberous sclerosis complex 2 (TSC2), resulted in the generation of highly glycolytic and potent effector CD8+ T cells; however, due to constitutive mTORC1 activation, these cells retained a terminally differentiated effector phenotype and were incapable of transitioning into a memory state. In contrast, CD8+ T cells deficient in mTORC1 activity due to loss of RAS homolog enriched in brain (RHEB) failed to differentiate into effector cells but retained memory characteristics, such as surface marker expression, a lower metabolic rate, and increased longevity. However, these RHEB-deficient memory-like T cells failed to generate recall responses as the result of metabolic defects. While mTORC1 influenced CD8+ T cell effector responses, mTORC2 activity regulated CD8+ T cell memory. mTORC2 inhibition resulted in metabolic reprogramming, which enhanced the generation of CD8+ memory cells. Overall, these results define specific roles for mTORC1 and mTORC2 that link metabolism and CD8+ T cell effector and memory generation and suggest that these functions have the potential to be targeted for enhancing vaccine efficacy and antitumor immunity.",
author = "Pollizzi, {Kristen N.} and Patel, {Chirag H.} and Sun, {Im Hong} and Oh, {Min Hee} and Waickman, {Adam T.} and Jiayu Wen and Delgoffe, {Greg M.} and Jonathan Powell",
year = "2015",
month = "5",
day = "1",
doi = "10.1172/JCI77746",
language = "English (US)",
volume = "125",
pages = "2090--2108",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation

AU - Pollizzi, Kristen N.

AU - Patel, Chirag H.

AU - Sun, Im Hong

AU - Oh, Min Hee

AU - Waickman, Adam T.

AU - Wen, Jiayu

AU - Delgoffe, Greg M.

AU - Powell, Jonathan

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Activation of mTOR-dependent pathways regulates the specification and differentiation of CD4+ T effector cell subsets. Herein, we show that mTOR complex 1 (mTORC1) and mTORC2 have distinct roles in the generation of CD8+ T cell effector and memory populations. Evaluation of mice with a T cell-specific deletion of the gene encoding the negative regulator of mTORC1, tuberous sclerosis complex 2 (TSC2), resulted in the generation of highly glycolytic and potent effector CD8+ T cells; however, due to constitutive mTORC1 activation, these cells retained a terminally differentiated effector phenotype and were incapable of transitioning into a memory state. In contrast, CD8+ T cells deficient in mTORC1 activity due to loss of RAS homolog enriched in brain (RHEB) failed to differentiate into effector cells but retained memory characteristics, such as surface marker expression, a lower metabolic rate, and increased longevity. However, these RHEB-deficient memory-like T cells failed to generate recall responses as the result of metabolic defects. While mTORC1 influenced CD8+ T cell effector responses, mTORC2 activity regulated CD8+ T cell memory. mTORC2 inhibition resulted in metabolic reprogramming, which enhanced the generation of CD8+ memory cells. Overall, these results define specific roles for mTORC1 and mTORC2 that link metabolism and CD8+ T cell effector and memory generation and suggest that these functions have the potential to be targeted for enhancing vaccine efficacy and antitumor immunity.

AB - Activation of mTOR-dependent pathways regulates the specification and differentiation of CD4+ T effector cell subsets. Herein, we show that mTOR complex 1 (mTORC1) and mTORC2 have distinct roles in the generation of CD8+ T cell effector and memory populations. Evaluation of mice with a T cell-specific deletion of the gene encoding the negative regulator of mTORC1, tuberous sclerosis complex 2 (TSC2), resulted in the generation of highly glycolytic and potent effector CD8+ T cells; however, due to constitutive mTORC1 activation, these cells retained a terminally differentiated effector phenotype and were incapable of transitioning into a memory state. In contrast, CD8+ T cells deficient in mTORC1 activity due to loss of RAS homolog enriched in brain (RHEB) failed to differentiate into effector cells but retained memory characteristics, such as surface marker expression, a lower metabolic rate, and increased longevity. However, these RHEB-deficient memory-like T cells failed to generate recall responses as the result of metabolic defects. While mTORC1 influenced CD8+ T cell effector responses, mTORC2 activity regulated CD8+ T cell memory. mTORC2 inhibition resulted in metabolic reprogramming, which enhanced the generation of CD8+ memory cells. Overall, these results define specific roles for mTORC1 and mTORC2 that link metabolism and CD8+ T cell effector and memory generation and suggest that these functions have the potential to be targeted for enhancing vaccine efficacy and antitumor immunity.

UR - http://www.scopus.com/inward/record.url?scp=84929008302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929008302&partnerID=8YFLogxK

U2 - 10.1172/JCI77746

DO - 10.1172/JCI77746

M3 - Article

VL - 125

SP - 2090

EP - 2108

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -